Congruence Therapeutics
Develops small molecule correctors for diseases of protein misfolding
$39.5MSeries B
Role not disclosedActivity from announced rounds
Develops small molecule correctors for diseases of protein misfolding
Develops high-resolution micro-ultrasound systems for urologic imaging